Tenet Healthcare (THC) reported solid Q2 results but its shares fell amid policy uncertainty around the Affordable Care Act exchanges, RBC Capital Markets said in a note Tuesday.
RBC analysts Ben Hendrix and Michael Murray said Q2 earnings call raised "widespread concern" over the operating backdrop for 2026 around the ACA exchanges, which is impairing visibility for hospital and payors alike into next year.
"We are not surprised to see management withhold preliminary views on 2026," the analysts said.
"Even so, THC remains our top hospital pick on strong
fundamentals, which we believe are not adequately reflected in the current multiple," they added.
RBC kept its $189 price target and outperform rating.
Price: 158.01, Change: +2.04, Percent Change: +1.31
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。